Alterations in the pattern and efficiency of alternative splicing of several pre-mRNAs (e.g. CD44, BRCA1, WT-1) have been implicated in tumorigenesis and correlate with tumour progression (Cooper and Dougherty, 1995; Liu et al, 2001). The gene discussed is CD44; the disease is neoplasm.